AI-driven uncertainty is reshaping healthcare IT (HCIT) dealmaking as buyers tread with caution and rethink valuations across the sector. While the sector remains fundamentally healthy, dealmakers say AI is increasingly impacting pricing, diligence and transaction structures. Against that backdrop, some exits are being postponed, amid an increasing focus on how much of today’s functionality could ultimately be dislodged by AI. Several health-tech assets expected to come to market this year have already been pushed into 2027 as sponsors reassess where multiples may settle, according to market participants.
Read the full article: AI-Driven Uncertainty Reframes Healthcare IT M&A //
Source: https://ionanalytics.com/insights/mergermarket/ai-driven-uncertainty-reframes-healthcare-it-ma/